These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 2781532

  • 1. Phosphotungstate shows a heparin-like anticoagulant effect but inhibits heparin.
    Tajima Y, Amagai H, Okamura N.
    Thromb Res; 1989 Aug 01; 55(3):329-39. PubMed ID: 2781532
    [Abstract] [Full Text] [Related]

  • 2. Heparin from bovine intestinal mucosa: glycans with multiple sulfation patterns and anticoagulant effects.
    Tovar AM, Capillé NV, Santos GR, Vairo BC, Oliveira SN, Fonseca RJ, Mourão PA.
    Thromb Haemost; 2012 May 01; 107(5):903-15. PubMed ID: 22437650
    [Abstract] [Full Text] [Related]

  • 3. Phosphotungstate as a useful eluent for antithrombin III purification by heparin-agarose affinity chromatography.
    Tajima Y, Shizuka R, Oshitani S, Amagai H.
    Thromb Res; 1990 Mar 01; 57(5):697-704. PubMed ID: 2339364
    [Abstract] [Full Text] [Related]

  • 4. The establishment and validation of efficient assays for anti-IIa and anti-Xa activities of heparin sodium and heparin calcium.
    Suzuki T, Ishii-Watabe A, Hashii N, Nakagawa Y, Takahashi T, Ebisawa A, Nishi S, Fujita N, Bando A, Sekimoto Y, Miyata K, Endo T, Otsu T, Sugimoto S, Kondou T, Fujita Y, Miyanaga N, Mashimo M, Shimada N, Yoden H, Shimamura H, Kurata Y, Koyama S, Kawasaki N.
    Biologicals; 2013 Nov 01; 41(6):415-23. PubMed ID: 24095600
    [Abstract] [Full Text] [Related]

  • 5. Effects of N-deacetylation and N-desulfation of heparin on its anticoagulant activity and in vivo disposition.
    Bjornsson TD, Schneider DE, Hecht AR.
    J Pharmacol Exp Ther; 1988 Jun 01; 245(3):804-8. PubMed ID: 3164387
    [Abstract] [Full Text] [Related]

  • 6. The inhibition of the anticoagulant activity of heparin by platelets, brain phospholipids, and tissue factor.
    Ofosu FA, Cerskus AL, Hirsh J, Smith LM, Modi GJ, Blajchman MA.
    Br J Haematol; 1984 Jun 01; 57(2):229-38. PubMed ID: 6733045
    [Abstract] [Full Text] [Related]

  • 7. Anticoagulant property of a semi-synthesized sodium beta-1,4-glucan sulfate.
    Wang ZM, Li L, Li B, Guo SY.
    Yao Xue Xue Bao; 2006 Apr 01; 41(4):323-7. PubMed ID: 16856476
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Human pharmacological studies of a defined low molecular weight heparin fraction (Fragmin) evidence for a simultaneous inhibition of factor Xa and IIa (thrombin).
    Andrassy K, Mörike K, Koderisch J, Weber E.
    Thromb Res; 1988 Mar 15; 49(6):601-11. PubMed ID: 3164530
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Synergistic effect of antithrombin III, activated protein C and heparin on the inhibition of the tissue thromboplastin-mediated coagulation.
    Hirahara K, Etoh Y, Matsuishi T, Suzuki N, Kurata M.
    Chem Pharm Bull (Tokyo); 1989 Mar 15; 37(3):692-6. PubMed ID: 2752479
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. In vivo age dependency of unfractionated heparin in infants and children.
    Newall F, Ignjatovic V, Summerhayes R, Gan A, Butt W, Johnston L, Monagle P.
    Thromb Res; 2009 Mar 15; 123(5):710-4. PubMed ID: 18829072
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.